U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675967) titled 'Clonal Hematopoiesis Chemotherapy and Radiation Effects Study' on June 15.
Brief Summary: The goal of the Clonal Hematopoiesis Chemotherapy and Radiation Effects (CH CARE) Study is to understand how the presence or absence of clonal hematopoiesis (CH) influences outcomes in people receiving chemotherapy and radiation for solid cancers.
The study will collect biospecimens and clinical information. These data will be used to define clinical and molecular features that predict the presence of high-risk clonal hematopoiesis (CH) in patients exposed to cytotoxic anti-cancer therapy. Predictive features will be utilized to identify popula...